OPEN END TURBO PUT-OPTIONSSCHEIN MIT SL - EDWARDS LIFESCIENCES | Market Closed - Deutsche Boerse AG 15:39:25 2024-05-17 EDT | ||
| 2.68 EUR | +4.28% |
|
| Current month | -14.38% | ||
| 1 month | -6.94% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-05-17 | 2.68 | +4.28% |
| 24-05-16 | 2.57 | -0.39% |
| 24-05-15 | 2.58 | -11.95% |
| 24-05-14 | 2.93 | -4.87% |
| 24-05-13 | 3.08 | +6.21% |
Delayed Quote Deutsche Boerse AG
Last update May 17, 2024 at 03:39 pm
More quotesStatic data
| Product type | Certificat Turbo Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Société Générale
|
| WKN | SV4HFP |
| ISIN | DE000SV4HFP6 |
| Date issued | 2023-04-18 |
| Strike | 118.2 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.93 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 5.37 € |
|---|---|
| Lowest since issue | 1.99 € |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
89.14
USD
Average target price
95.9
USD
Spread / Average Target
+7.59%
- Stock Market
- Certificates
- Certificat